ask="N/A"
ask_size="N/A"
average_daily_volume="284926"
bid="30.30"
bid_size="900"
book_value="6.19"
change="-0.57"
change_from_200_day_moving_average="1.63"
change_from_50_day_moving_average="0.92"
change_from_52_week_high="-6.52"
change_From_52_week_low="18.81"
change_in_percent="-1.73%"
close="32.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31720000"
high="33.36"
high_52_weeks="38.92"
last_trade_date="2/16/2017"
last_trade_price="32.40"
last_trade_size="21050"
last_trade_time="4:00pm"
low="31.89"
low_52_weeks="13.59"
market_capitalization="1.68B"
moving_average_200_day="30.77"
moving_average_50_day="31.48"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="33.10"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+5.29%"
percent_change_from_50_day_moving_average="+2.93%"
percent_change_from_52_week_high="-16.75%"
percent_change_from_52_week_low="+138.41%"
previous_close="32.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.32"
price_per_sales="36.55"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="19.05"
stock_exchange="NGM"
symbol="TBPH"
volume="167540"
weeks_range_52="13.59 - 38.92"
